Lonza Group Investor Relations Material
Latest events
CMD 2023
Lonza Group
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Lonza Group Ltd. engages in the manufacture and supply of products and services to the pharmaceutical, biotechnology, and diagnostic sectors. It operates through the Pharma & Biotech and Specialty Ingredients segments. The Pharma & Biotech segment includes active pharmaceutical ingredient active substances for therapeutic drugs for bacterial infections, anti-fungals, anti-virals, anti-cancer agents, cardiovasculars, gastrointestinal, and others. The Specialty Ingredients segment involves in the cosmetics ingredients business for personal care. Lonza Group was founded on December 5, 1897 and is headquartered in Basel.
Key slides for Lonza Group AG
CMD 2023
Lonza Group AG
CMD 2023
Lonza Group AG
Latest articles
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
The Story of Jensen Huang and Nvidia
When looking at NVIDIA’s Jensen Huang today, it is easy to stereotype him as your archetypical big tech CEO. He doesn’t wear suits like a Wall Street Chairman, instead opting to wear his now-iconic leather jackets and casual polo shirts.
6 Dec 2023
Neglect of Probability: A Hidden Risk in Decision Making
The concept of "probability" should take center stage in our decision-making processes.
4 Dec 2023
Ticker symbol
LONN
Country
🇨🇭 Switzerland